[1]
Kopniak, W. et al. 2026. Tirzepatide and semaglutide in obesity management and their impact on health-related quality of life – a comparative narrative review. Quality in Sport. 67, (Aug. 2026), 74311. DOI:https://doi.org/10.12775/QS.2026.67.74311.